Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonpharmacologic therapy for hypertension: does it really work?

Thor Tejada1, Alessia Fornoni, Oliver Lenz

  • 1University of Miami OPPRP, PO Box 016960, Miami, FL 33101, USA.

Current Cardiology Reports
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomically integrated orthogonal translation system in Escherichia coli enables production of functional modified [NiFe]-hydrogenases.

Microbial cell factories·2026
Same author

Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

No impact of low-dose nivolumab addition to JNJ-73763989 on HBsAg declines in chronic hepatitis B: the OCTOPUS-1 study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Rapid <i>in situ</i> encapsulation of [NiFe]-hydrogenase into covalent organic frameworks for robust hydrogen oxidation and evolution.

Chemical science·2026
Same author

Regulation of a catabolic enzyme whose substrate is always available.

mSystems·2026
Same author

siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares.

Journal of hepatology·2026

Lifestyle changes like weight loss, exercise, and dietary adjustments effectively manage hypertension. These nondrug therapies are crucial for preventing high blood pressure and complement medication for many patients.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Public Health

Background:

  • Hypertension is a significant global health concern.
  • Nondrug therapies are recognized for their potential in managing blood pressure.
  • Patient and physician motivation are key to successful lifestyle interventions.

Purpose of the Study:

  • To evaluate the efficacy of nondrug therapies in managing hypertension.
  • To assess the role of lifestyle modifications in preventing hypertension.
  • To highlight the benefits of integrating nondrug approaches with pharmacologic therapy.

Main Methods:

  • Review of established nondrug interventions for hypertension.
  • Analysis of blood pressure reduction associated with specific lifestyle changes.

Related Experiment Videos

  • Assessment of the impact of these therapies on hypertension risk.

    • Main Results:

    • Weight reduction can lower blood pressure by 5-20 mm Hg per 10 kg.
    • The Dietary Approach to Stop Hypertension (DASH) eating plan can reduce systolic blood pressure by 8-14 mm Hg.
    • Dietary sodium reduction, increased physical activity, and alcohol moderation also contribute to blood pressure lowering.
    • Combined interventions show additive benefits.
    • Tobacco cessation offers global health advantages and may reduce blood pressure.

    Conclusions:

    • Nondrug therapies are effective in managing hypertension and preventing its development.
    • Lifestyle modifications are essential for both preventing and treating hypertension.
    • These interventions serve as a valuable adjunct to pharmacologic therapy for most patients.